Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Pronalyse Unveils Therapeutic Enzyme Characterization Service for Your Drug Development

    May 24, 2022, 09:26 AM by
    Full story
  • Qlucore adds another cancer diagnostics area

    May 24, 2022, 09:26 AM by
    Qlucore, listed on Nasdaq First North, is delighted to announce a new collaboration in the field of precision diagnostics to develop solutions for improved clinical diagnostics of bladder cancer. Bladder cancer is the third classifier model co-operation launched by Qlucore in the area of solid tumours.
    Full story
  • Multi-omics Analysis Sheds Light on Drivers of Alzheimer’s Disease, Other Neurodegeneration

    May 24, 2022, 08:00 AM by User Not Found
    Bio-IT World | “I want to disabuse you of any illusion there exists black-box technologies where you can feed in data from multiple omics inputs and out comes interesting biology,” Shankar Subramaniam told the crowd in Boston earlier this month at the Bio-IT World Conference and Expo. “That’s a myth.”
    Full story
  • Kim Branson on Building Groundbreaking AI/ML GSK Models in Drug Discovery

    May 24, 2022, 01:00 AM by User Not Found
    Bio-IT World | Dr. Kim Branson’s long-standing fascination with small molecule drug discovery and structural biology led to an established career in machine learning. After studying in Australia, Branson trained at Stanford and now works as the Senior Vice President and Global Head of AI/ML at GlaxoSmithKline (GSK). In the latest episode of Bio-IT World’s Trends from the Trenches podcast, Branson and host, Stan Gloss, discuss machine learning, human genetics, functional genomics, and how each predicts various aspects of health.
    Full story
  • mdgroup Growth sees New VP, Product Delivery, Investing for the Future

    May 20, 2022, 09:10 AM by
    mdgroup Growth sees New VP, Product Delivery, Investing for the Future Bracknell, UK: 19 May 2022 – mdgroup, the leading global provider of healthcare technologies and personalised clinical study services, has charged its new VP, Product Delivery, Mohamad (Mo) Merhi, with doubling the development team and recruiting the highest calibre of global talent in technological development and innovation.
    Full story
  • BioMoti collaborates with global pharmaceutical company to develop ovarian cancer treatment and appoints Dr John Beadle as Chairman

    May 20, 2022, 09:10 AM by
    BioMoti Ltd today announces an agreement with a global pharmaceutical company to collaborate on the development of its lead ovarian cancer candidate, BMT101, to clinical phase 2a proof-of-concept.
    Full story
  • FDA grants 510k clearance of the CTL Amedica Navigation Instrument System

    May 19, 2022, 09:26 AM by
    CTL Amedica Corporation has received official 510k clearance from the U.S. FDA to market the CTL Amedica Navigation Instrument System, registration number K213491. The system features manual surgical instruments adaptable for use with third-party navigation systems, which are designed to assist surgeons in precisely locating anatomical structures for preparation and placement of pedicle screws.
    Full story
  • ZeOmega Unveils Novel Electronic Prior Authorization Solution

    May 19, 2022, 09:26 AM by
    Through Partnerships with Change Healthcare and MCG, ZeOmega’s HealthUnity™ Smart Authorization Gateway Saves Time, Lowers Costs and Reduces Delays in Patient Care
    Full story
  • BOC Sciences Officially Releases the Final Invitation to Renowned Pharma Conferences in May

    May 19, 2022, 09:25 AM by
    As the two industry-renowned exhibitions—CPhI North America and TIDES USA 2022 draw near, BOC Sciences is making final efforts to let the news reach as many researchers as possible, especially those who are struggling to find the best mRNA services.
    Full story
  • Carbohydrates of BOC Sciences Reveal Myriad Possibilities for Therapeutics

    May 19, 2022, 09:25 AM by
    BOC Sciences updated several carbohydrates and derivatives in July 2020 and has kept a constant enlargement of product categories since then. Currently, it provides a full spectrum of carbohydrates that dramatically boost the research in Glycochemistry, Glycobiology, Glyco-analytics, and other Glycosciences.
    Full story
  • LILLY RECEIVES MHRA MARKETING AUTHORISATION FOR ABEMACICLIB (VERZENIOS®▼) IN COMBINATION WITH ENDOCRINE THERAPY FOR ADJUVANT TREATMENT OF People with HR+, HER2- HIGH RISK EARLY BREAST CANCER

    May 19, 2022, 09:25 AM by
    Full story
  • Benchling Releases AlphaFold beta Integration

    May 19, 2022, 09:00 AM by User Not Found
    Bio-IT World | Benchling launched its AlphaFold beta feature today, designed to overcome challenges of implementation, computing power, and resourcing to make for ease of experimentation and integration with AlphaFold on the Benchling platform.
    Full story
  • Patient Advocacy Groups Band Together To Further Rare Disease Research

    May 19, 2022, 01:00 AM by User Not Found
    Bio-IT World | The fast-growing Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders (COMBINEDBrain) represents patient advocacy organizations for individuals with rare, neurodevelopmental diseases who are disadvantaged by the small number of affected individuals and scientific brainpower to lead the way.
    Full story
  • Four Well-Established Strategies Used in Hit Identification

    May 18, 2022, 09:21 AM by
    A successful hit identification campaign relies on the use of a high-quality, diverse library of potential compounds to be screened, but also on capitalizing on other complementary techniques, such as structure-based virtual screening (SBVS) and fragment-based screening.
    Full story
  • How to Synthesize Wax Esters? Three Synthetic Routes

    May 18, 2022, 09:21 AM by
    Wax esters are esters formed by long-chain fatty acids and fatty alcohols. Owing to their biodegradability and good lubricity, wax esters can be used as base materials for advanced lubricants and advanced emollient oils for aviation, machinery, and chemical industries as well as for daily cosmetics and other fields. Wax esters can be divided into saturated and unsaturated types.
    Full story
  • CD Formulation: How to Select Pharmaceutical Excipients

    May 18, 2022, 09:21 AM by
    Pharmaceutical excipients refer to the substances used in the production and formulation of medicines. They perform multiple functions in pharmaceutical preparations and are likely to affect the quality, safety and effectiveness of drugs.
    Full story
  • Alfa Chemistry Optimizes Its Microalgae Powder and Related Natural Extract Production Service

    May 18, 2022, 09:21 AM by
    Deeply impressed by the huge potential of microalgae, Alfa Chemistry recently announced to optimize its production systems for microalgae powder and other related natural extracts. This service was first launched a few years ago and ever since then, it has gained over 75 patents in the fields of breeding, cultivation, processing and extract. With a team of biologists, engineers and technicians who are highly experienced with microalgae, the company decides to upgrade its production services by introducing more systematic procedures and more advanced equipment.
    Full story
  • Alfa Chemistry Newly Releases the Offering of Forensic and Veterinary Standards

    May 18, 2022, 09:21 AM by
    Through years of dedicated efforts, Alfa Chemistry has become one of the most popular suppliers of analytical reagents among customers across the globe. Chromatography standards are one of the best-selling categories among all products the company provides, and endeavors have never ceased to enrich such an offering. As a result, this month Alfa Chemistry announces that it has started to offer forensic and veterinary standards, another type of chromatography standards that could be used for forensic and veterinary research.
    Full story
  • Dozens Of New Genetic Risk Factors For Alzheimer’s Disease Identified

    May 18, 2022, 01:00 AM by User Not Found
    Bio-IT World | A meta-analysis of new and previous genome-wide association studies (GWAS) has identified 75 genetic risk factors for Alzheimer’s disease (AD), 42 of which weren’t previously implicated. The investigation confirms the importance of two pathological brain phenomena that are currently pursued therapeutic targets and strengthens the case for having microglial cells join the hit list, according to Jean-Charles Lambert, research director at Inserm (National Institute of Health and Medical Research) based in Lille, France.
    Full story
  • BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421, for Dry Eye Syndrome

    May 17, 2022, 15:46 PM by
    BRIM Biotechnology, Inc. (“BRIM”), a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. (“ORA”), the world’s leading ophthalmic research organization for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM intends to initiate Phase 3 clinical studies with Ora’s support later this year.
    Full story
  • «
  • 131
  • 132
  • 133
  • 134
  • 135 (current)
  • 136
  • 137
  • 138
  • 139
  • 140
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy